BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 15972724)

  • 1. Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice.
    Mounkes LC; Kozlov SV; Rottman JN; Stewart CL
    Hum Mol Genet; 2005 Aug; 14(15):2167-80. PubMed ID: 15972724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of late sodium current attenuates ionic arrhythmia mechanism in ventricular myocytes expressing LaminA-N195K mutation.
    Markandeya YS; Tsubouchi T; Hacker TA; Wolff MR; Belardinelli L; Balijepalli RC
    Heart Rhythm; 2016 Nov; 13(11):2228-2236. PubMed ID: 27498076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies.
    Arimura T; Helbling-Leclerc A; Massart C; Varnous S; Niel F; Lacène E; Fromes Y; Toussaint M; Mura AM; Keller DI; Amthor H; Isnard R; Malissen M; Schwartz K; Bonne G
    Hum Mol Genet; 2005 Jan; 14(1):155-69. PubMed ID: 15548545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
    van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
    Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dilated cardiomyopathy caused by LMNA mutations. Clinical and morphological studies.
    Bilińska ZT; Sylvius N; Grzybowski J; Fidziańska A; Michalak E; Walczak E; Walski M; Bieganowska K; Szymaniak E; Kuśmierczyk-Droszcz B; Lubiszewska B; Wagner T; Tesson F; Ruzyłło W
    Kardiol Pol; 2006 Aug; 64(8):812-9; discussion 820-1. PubMed ID: 16981056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diseases associated with lamin A/C gene defects: what the clinical cardiologist ought to know].
    Pasotti M; Repetto A; Pisani A; Arbustini E
    Ital Heart J Suppl; 2004 Feb; 5(2):98-111. PubMed ID: 15080529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional consequences of an LMNA mutation associated with a new cardiac and non-cardiac phenotype.
    Charniot JC; Pascal C; Bouchier C; Sébillon P; Salama J; Duboscq-Bidot L; Peuchmaurd M; Desnos M; Artigou JY; Komajda M
    Hum Mutat; 2003 May; 21(5):473-81. PubMed ID: 12673789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy.
    Taylor MR; Slavov D; Gajewski A; Vlcek S; Ku L; Fain PR; Carniel E; Di Lenarda A; Sinagra G; Boucek MM; Cavanaugh J; Graw SL; Ruegg P; Feiger J; Zhu X; Ferguson DA; Bristow MR; Gotzmann J; Foisner R; Mestroni L;
    Hum Mutat; 2005 Dec; 26(6):566-74. PubMed ID: 16247757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiac manifestations of laminopathies].
    Brette S; Penisson-Besnier I; Dupuis JM; Bonne G; Victor J
    Arch Mal Coeur Vaiss; 2004 Oct; 97(10):973-7. PubMed ID: 16008174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity.
    Cattin ME; Bertrand AT; Schlossarek S; Le Bihan MC; Skov Jensen S; Neuber C; Crocini C; Maron S; Lainé J; Mougenot N; Varnous S; Fromes Y; Hansen A; Eschenhagen T; Decostre V; Carrier L; Bonne G
    Hum Mol Genet; 2013 Aug; 22(15):3152-64. PubMed ID: 23575224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of mechanical stress and carvedilol in lamin A/C-deficient dilated cardiomyopathy.
    Chandar S; Yeo LS; Leimena C; Tan JC; Xiao XH; Nikolova-Krstevski V; Yasuoka Y; Gardiner-Garden M; Wu J; Kesteven S; Karlsdotter L; Natarajan S; Carlton A; Rainer S; Feneley MP; Fatkin D
    Circ Res; 2010 Feb; 106(3):573-82. PubMed ID: 20019332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients.
    Sylvius N; Bilinska ZT; Veinot JP; Fidzianska A; Bolongo PM; Poon S; McKeown P; Davies RA; Chan KL; Tang AS; Dyack S; Grzybowski J; Ruzyllo W; McBride H; Tesson F
    J Med Genet; 2005 Aug; 42(8):639-47. PubMed ID: 16061563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins.
    Al-Saaidi R; Rasmussen TB; Palmfeldt J; Nissen PH; Beqqali A; Hansen J; Pinto YM; Boesen T; Mogensen J; Bross P
    Exp Cell Res; 2013 Nov; 319(19):3010-9. PubMed ID: 24001739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear lamins, diseases and aging.
    Mattout A; Dechat T; Adam SA; Goldman RD; Gruenbaum Y
    Curr Opin Cell Biol; 2006 Jun; 18(3):335-41. PubMed ID: 16632339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear accumulation of androgen receptor in gender difference of dilated cardiomyopathy due to lamin A/C mutations.
    Arimura T; Onoue K; Takahashi-Tanaka Y; Ishikawa T; Kuwahara M; Setou M; Shigenobu S; Yamaguchi K; Bertrand AT; Machida N; Takayama K; Fukusato M; Tanaka R; Somekawa S; Nakano T; Yamane Y; Kuba K; Imai Y; Saito Y; Bonne G; Kimura A
    Cardiovasc Res; 2013 Aug; 99(3):382-94. PubMed ID: 23631840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice.
    Nikolova V; Leimena C; McMahon AC; Tan JC; Chandar S; Jogia D; Kesteven SH; Michalicek J; Otway R; Verheyen F; Rainer S; Stewart CL; Martin D; Feneley MP; Fatkin D
    J Clin Invest; 2004 Feb; 113(3):357-69. PubMed ID: 14755333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamin A/C and cardiac diseases.
    Sylvius N; Tesson F
    Curr Opin Cardiol; 2006 May; 21(3):159-65. PubMed ID: 16601451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obliteration of cardiomyocyte nuclear architecture in a patient with LMNA gene mutation.
    Fidziańska A; Bilińska ZT; Tesson F; Wagner T; Walski M; Grzybowski J; Ruzyłło W; Hausmanowa-Petrusewicz I
    J Neurol Sci; 2008 Aug; 271(1-2):91-6. PubMed ID: 18502446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connexin 43 remodeling induced by LMNA gene mutation Glu82Lys in familial dilated cardiomyopathy with atrial ventricular block.
    Sun LP; Wang L; Wang H; Zhang YH; Pu JL
    Chin Med J (Engl); 2010 Apr; 123(8):1058-62. PubMed ID: 20497714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.
    Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG
    J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.